Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects
NCT01079273
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
egg-derived A/H1N1 pandemic influenza vaccine
Sponsor
Opera CRO, a TIGERMED Group Company